<DOC>
	<DOC>NCT00069459</DOC>
	<brief_summary>A placebo controlled study evaluating the effectiveness of medication in preventing winter depressive episodes in patients with a history of Seasonal Affective Disorder</brief_summary>
	<brief_title>Seasonal Affective Depression (SAD) Study</brief_title>
	<detailed_description>A 7-Month Multicenter, Parallel, Double-Blind, Placebo-Controlled Comparison of 150-300mg/day of Extended-release Bupropion Hydrochloride and Placebo for the Prevention of Seasonal Depressive Episodes in Subjects with a History of Seasonal Affective Disorder Followed by an 8-week Observational Follow-up Phase</detailed_description>
	<mesh_term>Mood Disorders</mesh_term>
	<mesh_term>Seasonal Affective Disorder</mesh_term>
	<mesh_term>Bupropion</mesh_term>
	<criteria>History of Major Depressive Disorder (MDD) with a seasonal pattern. Current or past history of seizure disorder or brain injury. History or current diagnosis of anorexia nervosa or bulimia. Recurrent summer depression more frequently than winter depression. Primary diagnosis of panic disorder, Obsessive Compulsive Disorder (OCD), Posttraumatic Stress Disorder(PTSD), acute distress disorder, bipolar II disorder or other psychotic disorders. Initiated psychotherapy within the last 3 months.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Winter depression, winter blues, depression, seasonal depression, seasonal affective disorder</keyword>
</DOC>